| Primary |
| Prevention |
44.4% |
| Drug Use For Unknown Indication |
11.1% |
| Anxiety Reaction |
5.6% |
| Cholestasis |
5.6% |
| Hypertension |
5.6% |
| Hypothyroidism |
5.6% |
| Immunosuppression |
5.6% |
| Insomnia |
5.6% |
| Prophylaxis Against Diarrhea |
5.6% |
| Vitamin B12 Deficiency |
5.6% |
|
| Thrombotic Microangiopathy |
100.0% |
|
| Secondary |
| Premedication |
15.9% |
| Drug Use For Unknown Indication |
15.3% |
| Prophylaxis |
14.8% |
| Drug Exposure During Pregnancy |
13.1% |
| Product Used For Unknown Indication |
7.9% |
| Chemotherapy |
3.5% |
| Cord Blood Transplant Therapy |
2.9% |
| Cytomegalovirus Infection |
2.9% |
| Pyrexia |
2.6% |
| Laryngeal Cancer |
2.5% |
| Insomnia |
2.2% |
| Cholestasis |
2.0% |
| Hypertension |
2.0% |
| Immunosuppression |
2.0% |
| Antiemetic Supportive Care |
1.9% |
| Anxiety |
1.7% |
| Hypothyroidism |
1.7% |
| Mantle Cell Lymphoma Recurrent |
1.7% |
| Lymphoma |
1.6% |
| Nausea |
1.6% |
|
| Thrombotic Microangiopathy |
14.7% |
| Vomiting |
12.0% |
| Premature Baby |
6.7% |
| Rash Erythematous |
5.3% |
| Staphylococcal Infection |
5.3% |
| Thrombocytopenia |
5.3% |
| Cardiac Arrest |
4.0% |
| Hot Flush |
4.0% |
| Hypogonadism |
4.0% |
| Pruritus |
4.0% |
| Purpura |
4.0% |
| Pyrexia |
4.0% |
| Rash |
4.0% |
| Renal Failure Acute |
4.0% |
| Skin Hyperpigmentation |
4.0% |
| Toxic Skin Eruption |
4.0% |
| Erythema |
2.7% |
| Jaundice Neonatal |
2.7% |
| Mucosal Inflammation |
2.7% |
| Parkinsonism |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
34.8% |
| Sarcoma |
10.2% |
| Drug Use For Unknown Indication |
6.4% |
| Rhabdomyosarcoma |
5.9% |
| Acute Lymphocytic Leukaemia |
5.2% |
| Acute Myeloid Leukaemia |
4.9% |
| Pyrexia |
4.3% |
| Nausea |
3.7% |
| Premedication |
3.6% |
| Pain |
3.1% |
| Unevaluable Event |
2.9% |
| Vomiting |
2.8% |
| Bone Marrow Conditioning Regimen |
2.6% |
| Prophylaxis |
2.4% |
| Prophylaxis Of Nausea And Vomiting |
1.8% |
| Bone Sarcoma |
1.4% |
| Acute Lymphocytic Leukaemia Recurrent |
1.1% |
| Colorectal Cancer |
1.0% |
| Ovarian Cancer |
1.0% |
| Anxiety |
0.9% |
|
| Vomiting |
16.2% |
| Mucosal Inflammation |
9.5% |
| Skin Exfoliation |
8.6% |
| Peripheral Sensorimotor Neuropathy |
5.7% |
| Thrombocytopenia |
4.8% |
| Toxoplasmosis |
4.8% |
| Hemiplegia |
3.8% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
3.8% |
| Pruritus |
3.8% |
| Pyrexia |
3.8% |
| Rash |
3.8% |
| Renal Failure |
3.8% |
| Renal Failure Acute |
3.8% |
| Sepsis |
3.8% |
| Staphylococcal Infection |
3.8% |
| Toxic Epidermal Necrolysis |
3.8% |
| Toxicity To Various Agents |
3.8% |
| Neuralgia |
2.9% |
| Non-cardiac Chest Pain |
2.9% |
| Stevens-johnson Syndrome |
2.9% |
|
